Home › Funds › Affinity Asset Advisors, LLC › ERAS
Affinity Asset Advisors, LLC position in ERAS
ERASCA INC · Health Care
Affinity Asset Advisors, LLC reported holding 5,590,600 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$82.0M, representing 3.82% of its reported portfolio and ranking #5 among its reported holdings. Affinity Asset Advisors, LLC has disclosed ERAS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Affinity Asset Advisors, LLC's ERAS position evolved
Affinity Asset Advisors, LLC first disclosed a stake in ERAS in Q2 2024 at 2,499,431 shares (US$5.9M). The position peaked in Q2 2026 at 5,250,000 shares, worth US$96.2M. Across 10 filings, Affinity Asset Advisors, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 5,590,600 shares valued at US$82.0M — an increase of 340,600 shares quarter over quarter.. Notable position changes include a 34% increase in Q1 2025 (shares fell 7% over the following quarter), a 37% increase in Q1 2026 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 2.50M | $5.90M | New |
| Q3 2024 | 2.50M | $6.82M | Hold |
| Q4 2024 | 2.50M | $6.27M | Hold |
| Q1 2025 | 3.34M | $4.58M | Add |
| Q2 2025 | 4.09M | $5.19M | Add |
| Q3 2025 | 4.29M | $9.34M | Add |
| Q4 2025 | 3.90M | $14.51M | Reduce |
| Q1 2026 | 5.35M | $86.56M | Add |
| Q2 2026 | 5.25M | $96.18M | Reduce |
| Q3 2026 | 5.59M | $81.96M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 73 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 24.98M sh · $457.55M · Q2 2026
- RTW INVESTMENTS, LP 17.95M sh · $328.78M · Q2 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Logos Global Management LP 12.15M sh · $222.59M · Q2 2026
- Siren, L.L.C. 13.20M sh · $193.48M · Q3 2026
- Paradigm Biocapital Advisors LP 9.55M sh · $174.96M · Q2 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Vivo Capital, LLC 4.02M sh · $58.94M · Q3 2026
- a16z Capital Management, L.L.C. 2.86M sh · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- SAMLYN CAPITAL, LLC 2.26M sh · $41.35M · Q2 2026
More on Affinity Asset Advisors, LLC
FAQ
How long has Affinity Asset Advisors, LLC held ERAS?
Affinity Asset Advisors, LLC has disclosed ERAS holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Affinity Asset Advisors, LLC's current position in ERAS?
As of Q3 2026, Affinity Asset Advisors, LLC holds 5.59M shares of ERAS (ERASCA INC), valued at $81.96M, representing 3.82% of its reported portfolio and ranking #5.
Has Affinity Asset Advisors, LLC been buying or selling ERAS?
In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in ERAS. The position peaked in Q2 2026 at 5.25M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.